Home > Boards > US OTC > Medical - Equipment > Positron Corporation (POSC)

I agree, cardiac PET is already gaining significant

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
zenvesting Member Profile
 
Followed By 98
Posts 2,843
Boards Moderated 3
Alias Born 02/10/04
160x600 placeholder
zenvesting   Saturday, 09/19/20 12:15:04 PM
Re: aapples1992 post# 19407
Post # of 19426 
I agree, cardiac PET is already gaining significant traction with the coalition of industry organizations that teamed up to defend medicare reimbursement rates for cardiac PET last year.

It looks like cardiac PET will be ready to overtake SPECT for myocardial perfusion imaging (MPI) when Flurpiridaz F-18 gets FDA approval, now expected in early 2023. Thousands of PET cameras will be needed and Positron is well positioned to benefit when that demand comes.

"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences